Riskpilot← Back to searchSign inGet full accessAlmedo AB
ABActiveOrg 5566541081Björkvägen 10Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20042 employees
Revenue 2024
SEK 4,1M
+19% vs 2023
EBITDA margin
5.3%
+131% vs 2023
Equity ratio
48.7%
Financial strength
Net profit 2024
SEK 203K
+129% vs 2023
| Revenue | SEK 4,1M | +19% |
| EBITDA | SEK 217K | +131% |
| Net profit | SEK 203K | +129% |
| Total assets | SEK 1,6M | -1% |
| Equity | SEK 765K | +36% |
| Employees | 2 | — |
Legal name
Almedo AB
Org number
5566541081
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
22 januari 2004
Share capital
SEK 250 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva handel med medicinteknisk utrustning samt därmed förenlig verksamhet.
Address
Björkvägen 10
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 175 | 5 051 | 3 815 | 3 428 | 4 080 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −276 | 1 080 | −29 | −699 | 217 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −276 | 1 080 | −29 | −699 | 217 |
| Net financials | −28 | −12 | 10 | −8 | −15 |
| Profit before tax | −304 | 1 068 | −19 | −707 | 203 |
| Tax | −0 | −167 | −0 | −0 | −0 |
| Net profit | −304 | 901 | −19 | −707 | 203 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 245 | 3 003 | 2 099 | 1 593 | 1 570 |
| Equity | 988 | 1 889 | 1 269 | 563 | 765 |
| Long-term debt | 162 | 12 | 0 | 270 | 0 |
| Short-term debt | 1 096 | 1 102 | 830 | 760 | 805 |
| Total debt | 1 258 | 1 114 | 830 | 1 030 | 805 |
EBITDA margin
5.3%
This company
15.8%
Market median
-66% vs market
20202024
Equity ratio
48.7%
This company
38.2%
Market median
+27% vs market
20202024
Return on equity
26.5%
This company
18.4%
Market median
+44% vs market
20202024
Net profit margin
5.0%
This company
8.1%
Market median
-38% vs market
20202024
Asset turnover
2.60×
This company
1.12×
Market median
+132% vs market
20202024
Debt / equity
1.05×
This company
0.62×
Market median
-69% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LG Chief Executive Officer | Chief Executive Officer | 2022 |
CM Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Almedo AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif-Anders Gerhard Douhm | Chief Executive Officer | 0 companies |
| Claes Mikael Jennel | Audit | 0 companies |
| Kerstin Margareta Ygberg Douhm | Deputy Board Member | 0 companies |
| Karl Heinz Alf Gerhard Douhm | Chairman | 0 companies |